Dina Tzemach - Concepedia

Concepedia

Author

Dina Tzemach

Shaare Zedek Medical Center

Also Known As

D Tzemach, D. Tzemach, DINA TZEMACH, Dina Tzemach

21

Publications

1.8K

Citations

16

H-Index

35

Concepts

All Affiliations

Shaare Zedek Medical Center Hebrew University of Jerusalem Hadassah Medical Center

DT

About

Dina Tzemach is an author at Shaare Zedek Medical Center specializing in pharmacology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Natural Sciences	2	2	79
3	Engineering	1	1	49
4	Health Sciences	1	1	94
5	Applied Physics	1	1	49

Dina Tzemach

×

16

Publications

1.8K

Citations

16

H-Index

	Year	Citations
Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Dorit Goren, Aviva T. Horowitz, Dina Tzemach, PubMed NanotherapeuticsExtracellular MicrovesiclesCancer BiologyTumor BiologyNuclear Delivery	2000	402
In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Alberto Gabizón, Aviva T. Horowitz, Dorit Goren, PubMed	2003	295
Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors Hilary Shmeeda, Lidia Mak, Dina Tzemach, Molecular Cancer Therapeutics	2006	138
Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models Suzan Bandak, Dorit Goren, Aviva T. Horowitz, Anti-Cancer Drugs	1999	138
Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models Alberto Gabizón, Dina Tzemach, Jenny Gorin, Cancer Chemotherapy and Pharmacology Drug TargetingMedicinePharmacologyTherapeutic ActivityFolate-targeted Liposomal Doxorubicin	2009	116
An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin Alberto Gabizón, Rut Isacson, Ora Rosengarten, Cancer Chemotherapy and Pharmacology Pharmaceutical SciencePharmacologyLiposomal DoxorubicinPharmacotherapyCycle Dependence	2007	110
Her2-targeted pegylated liposomal doxorubicin: Retention of target-specific binding and cytotoxicity after in vivo passage Hilary Shmeeda, Dina Tzemach, Lidia Mak, Journal of Controlled Release Drug TargetingVivo PassageTarget-specific BindingPolymer-drug ConjugateMedicine	2009	96
Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells Hilary Shmeeda, Yasmine Amitay, Jenny Gorin, Journal of Controlled Release Cell-based Drug DeliveryNanomedicineZoledronic AcidDrug TargetingPolymer-drug Conjugate	2010	94
Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity Hilary Shmeeda, Yasmine Amitay, Dina Tzemach, Journal of Controlled Release Lipid PreparationNanomedicineZoledronic Acid ResultsBiochemistryMedicine	2013	72
Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with Glucocorticoids Yuval Avnir, Keren Turjeman, Deborah Tulchinsky, PLoS ONE	2011	70

Page 1